Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK ...

Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

Fire1 announced today that it completed a $120 million financing round to accelerate the advancement of its heart failure ...

ST. MARYS — Joint Township District Memorial Hospital earned an advanced heart failure certification from the DNV, a global certification and risk management company for health systems.

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Medically reviewed by Jeffrey S. Lander, MD Living with heart failure requires careful monitoring as well as some major ...